ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 84 filers reported holding ANTARES PHARMA INC in Q4 2013. The put-call ratio across all filers is 0.62 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q1 2015 | $1,000 | 0.0% | 500 | 0.0% | 0.00% | – |
| Q4 2014 | $1,000 | -50.0% | 500 | -50.0% | 0.00% | – |
| Q3 2014 | $2,000 | -33.3% | 1,000 | 0.0% | 0.00% | – |
| Q2 2014 | $3,000 | -62.5% | 1,000 | -50.0% | 0.00% | -100.0% |
| Q1 2014 | $8,000 | +100.0% | 2,000 | +100.0% | 0.00% | 0.0% |
| Q4 2013 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WILLIAM HARRIS INVESTORS INC | 2,338,735 | $6,244,000 | 1.73% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 9,603,703 | $25,642,000 | 1.03% |
| Broadfin Capital, LLC | 6,100,000 | $16,288,000 | 0.80% |
| ASHFORD CAPITAL MANAGEMENT INC | 1,088,675 | $2,907,000 | 0.58% |
| MARINER INVESTMENT GROUP LLC | 296,477 | $792,000 | 0.15% |
| THOMPSON DAVIS & CO., INC. | 36,500 | $97,000 | 0.14% |
| Peregrine Asset Advisers, Inc. | 53,034 | $142,000 | 0.13% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,165,738 | $3,101,000 | 0.12% |
| Avenir Corp | 341,035 | $911,000 | 0.08% |
| Brown Advisory Securities, LLC | 50,550 | $135,000 | 0.05% |